|
|
Post by Hot Christian Stocks on Jan 23, 2014 9:49:57 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Jan 23, 2014 10:18:26 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Jan 24, 2014 9:06:08 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Jan 26, 2014 21:09:57 GMT -5
$PLPL Former Microsoft Exec marijuana Entrepreneur co-founded Diego Pellicer, Inc Shively plans to launch a study of the effectiveness of concentrated cannabis oil in the treatment of cancer and other illnesses NEW YORK, NY -- (Marketwired) -- 01/24/14 Seattle is famous for its coffee and even more famous for Starbucks. That's the coffee chain no one ever imagined could blossom into a more than $50 billion business selling a cup of Joe. Well, don't look now but the city may soon be home to another retail chain that stakes its future on a single product, but this time it's marijuana and one man is trying to make that a reality. Former Microsoft exec Jamen Shively has become quite a recognizable name in the marijuana debate, and his recognition may very well be Plandaí Biotechnology's (OTCQB: PLPL) gain. Shively is no stranger to marijuana as the great-great grandson of Diego Pellicer, the former Vice Governor of the Philippine Island of Cebu and the largest grower of hemp in the world in the late 1800s. Diego Pellicer once supplied hemp rope to the Spanish Armada during the Spanish American War. The marijuana entrepreneur co-founded Diego Pellicer, Inc. to create the first retail brand of cannabis in the U.S. and eventually worldwide. Marijuana, both legal and black market, is a $100 billion a year industry in the U.S. alone, a number not lost on Shively, "It's a giant market in search of a brand. We would be happy if we get 40 percent of it worldwide." It was likely his Microsoft stint that made Shively a media darling of sorts after he announced his vision to become the leader in both medical and recreational cannabis. Since that proclamation, he's found his name in many national headlines and has been a guest on just about every news program from CNN to FOX Business to ABC News. Dope Magazine even suggested Shively might be the "Bill Gates of Cannabis." Shively also plans to launch a study of the effectiveness of concentrated cannabis oil in the treatment of cancer and other illnesses, and it's this desire to enter the medical side of marijuana that Plandaí hopes to capitalize on. Plandaí announced a week ago that it has partnered with Diego Pellicer, Inc. and Diego Pellicer Worldwide Inc. to use the Diego Pellicer name on its Phytofare medical and pharmaceutical cannabis extracts. This is a genius idea for both Plandaí and Shively because it allows the biotech firm to build brand recognition for its cannabis products while the industry continues to deal with legislation, legalization and growth; meanwhile, for Shively, it allows his brand to be associated with medical marijuana products. Shively said of the agreement, "We couldn't be happier with our partnership with Plandaí. Their Phytofare technology appears to be years ahead of the competition as it relates to bioavailability and will help anchor the Diego brand as more states legalize cannabis for medical and/or recreational applications." Let's face it no matter how controversial the debate, Jamen Shively has a platform and a rather large one at that, and it's that platform that should allow Diego Pellicer to become the brand at the tip of your tongue when you discuss cannabis. So, for Plandaí, that's not a bad ride to be on in what is the hottest debate in the country. www.stockwatch.com/News/Item.aspx?bid=U-i1084380-U%3aPLPL-20140124&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Jan 27, 2014 10:09:56 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Jan 28, 2014 9:47:13 GMT -5
$PLPL Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing the patented pending Phytofare™ extracts in-house allowing the Company to guarantee the continuity of supply as well as quality control throughout Targeted industries for the Company's products include food and beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit www.plandaibiotech.com |
|
|
|
Post by Hot Christian Stocks on Jan 29, 2014 9:48:32 GMT -5
Plandaí Biotechnology, Inc. (OTCQB: $PLPL ), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that it has been featured in the October 18th edition of Farmer's Weekly (www.farmersweekly.co.za). The article discusses the history of South African tea farming, the changes and renovations implemented by Plandaí to rejuvenate the tea industry, and the potential impact of the business on the local economy. www.farmersweekly.co.za/article.aspx?id=47167&h=Green-tea-revival |
|
|
|
Post by Hot Christian Stocks on Jan 30, 2014 11:02:24 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Jan 31, 2014 9:48:59 GMT -5
$PLPL is likely going to be mentioned again and again on television networks like CBS, CNN, CNBC, FOX, and ABC NEW YORK, NY--(Marketwired - Jan 30, 2014) - When Plandaí Biotechnology (OTCQB: PLPL) entered into an agreement with Diego Pellicer and Diego Pellicer Worldwide to brand its Phytofare™ Cannabis extracts, one has to wonder if the company knew just how big a media platform its new partner has. If you're an investor in Plandaí, it might be time to get excited about who your company is partnered with. The media and its microphones showed up in large numbers at a Seattle press conference where marijuana entrepreneur and Diego Pellicer co-founder Jamen Shively announced he would be creating the first retail brand of marijuana in the United States. Shively, a former Microsoft executive, was flanked by the former president of Mexico, Vicente Fox as he presented his plans to capture 40 percent of the worldwide marijuana market and answered a host of questions from the media. In the days, weeks and months following that event, Shively has been interviewed by just about every media publication, and he's made the rounds on all the network and cable news shows. The media loves Jamen Shively, and if he has something to say, they'll provide the platform for him to say it. He's not alone though. Just yesterday CBS News called on Diego Pellicer's CEO, Ron Throgmartin, to discuss the industry since Colorado began selling recreational marijuana legally this month. In the interview, Throgmartin predicted marijuana will be legalized nationwide in as little as two years. "I think by 2016 California will go legal. And, I think once a state the size of California goes, I think, the rest of the country follows." One thing is clear, when Plandaí begins to market its Cannabis extracts under the Diego Pellicer brand, the company's name is likely going to be mentioned again and again on television networks like CBS, CNN, CNBC, FOX, and ABC. It's the genius in the partnership -- because while every other public company awaits legalization, Plandaí will be building its brand! CBS News Interview: www.cbsnews.com/news/legal-pot-dispensaries-high-on-profits/finance.yahoo.com/news/plandai-biotechnologys-cannabis-extracts-destined-133000485.html?soc_src=mediacontentstory |
|
|
|
Post by Hot Christian Stocks on Jan 31, 2014 10:10:20 GMT -5
We have been bringing you PLPL for several weeks now PLPL has gains of more than 350% since our first alert!
We BROUGHT PLPL TO YOU AT .45 TO SEE HIGH ALREADY THIS MORNING AT $1.73
Stay tuned, this is going to be a Big one!
Plandai Biotechnology's Cannabis Extracts Destined for Network and Cable News
NEW YORK, NY--(Marketwired - Jan 30, 2014) - When Plandaí Biotechnology (OTCQB: PLPL) entered into an agreement with Diego Pellicer and Diego Pellicer Worldwide to brand its Phytofare™ Cannabis extracts, one has to wonder if the company knew just how big a media platform its new partner has. If you're an investor in Plandaí, it might be time to get excited about who your company is partnered with. The media and its microphones showed up in large numbers at a Seattle press conference where marijuana entrepreneur and Diego Pellicer co-founder Jamen Shively announced he would be creating the first retail brand of marijuana in the United States.
Shively, a former Microsoft executive, was flanked by the former president of Mexico, Vicente Fox as he presented his plans to capture 40 percent of the worldwide marijuana market and answered a host of questions from the media. In the days, weeks and months following that event, Shively has been interviewed by just about every media publication, and he's made the rounds on all the network and cable news shows.
The media loves Jamen Shively, and if he has something to say, they'll provide the platform for him to say it. He's not alone though. Just yesterday CBS News called on Diego Pellicer's CEO, Ron Throgmartin, to discuss the industry since Colorado began selling recreational marijuana legally this month.
In the interview, Throgmartin predicted marijuana will be legalized nationwide in as little as two years. "I think by 2016 California will go legal. And, I think once a state the size of California goes, I think, the rest of the country follows."
One thing is clear, when Plandaí begins to market its Cannabis extracts under the Diego Pellicer brand, the company's name is likely going to be mentioned again and again on television networks like CBS, CNN, CNBC, FOX, and ABC. It's the genius in the partnership -- because while every other public company awaits legalization, Plandaí will be building its brand!
About Stock Market Media Group SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures: www.stockmarketmediagroup.com.
Stock Market Media Group Email Contact
Plandai Biotechnology's Future in Marijuana Industry Boosted by Talk of Banking Access
NEW YORK, NY--(Marketwired - Jan 27, 2014) - Plandaí Biotechnology (OTCQB: PLPL) will establish its footprint in the marijuana industry with its Phytofare™ cannabis extracts. With that in mind, it partnered with retail brand, Diego Pellicer, Inc., and its co-founder, former Microsoft executive, Jamen Shively who has plans to capture 40 percent of the marijuana business worldwide. So, the plan is in place and Plandaí is fortunate to be able to brand itself with a partner who has a very large platform and loud voice in the industry. But, it's the voices in Washington these days that seem to be injecting a great deal of hope to those running legitimate cannabis businesses in the U.S.
First it was President Obama all but endorsing future legalization by stating the drug is no more dangerous than alcohol, and by citing that support for both Washington and Colorado's recent legalization of marijuana is necessary for fairness purposes given some are being arrested and incarcerated for the illegal drug while others face no penalties at all. This declaration seemed to suggest that nationwide legalization would be fair if regulated.
Well, now an even bigger statement is coming out of Attorney General Eric Holder. Late last week Holder stated that the Administration will soon announce regulations to make it easier for banks to do business with legal marijuana businesses.
The banking piece of the cannabis equation is crucial to the future of the industry and for those companies running a legitimate cannabis business. Even Holder recognizes that a business surviving on all cash poses a number of problems. It appears the administration may use the "safety concerns" angle of having large amounts of cash lying around to introduce regulations that allow legitimate businesses to deposit money into U.S. banks.
To those operating a legitimate cannabis business, just having the Justice Department and the Treasury at the table discussing the industry is a large step forward in a debate that seems to be shifting almost overnight.
About Stock Market Media Group
SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures: www.stockmarketmediagroup.com.
Contact Information
Contact: Stock Market Media Group Email Contact
 Disclaimer: Rockingpennystocks.com. This email and the content provided is intended for advertisement purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our e-mail list. PLEASE NOTE: Rockingpennystocks employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at www.Rockingpennystocks.com/disclaimer.php Release of Liability: Through use of this website/newsletter viewing or using you agree to hold Rockingpennystocks its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources, which we believe to be reliable, but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Rockingpennystocks affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. Rockingpennystocks.com encourages readers and investors to supplement the information in these reports with independent research and other pro advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Rockingpennystocks makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Rockingpennystocks.com often receives compensation for marketing, awareness and investor relation services, which can be reviewed within our disclaimer. Rockingpennystocks.com has been compensated $1500 cash for the distribution of this email and other marketing services from a non controlling third party. We may or may not hold a position and reserve the right to buy or sell shares at any time, which may positively or negatively affect the price per share. This not a solicitation to buy or sell any securities. Rockingpennystocks nor any of its affiliates are registered investment advisers or broker dealers.
 |
|
|
|
Post by Hot Christian Stocks on Feb 3, 2014 9:54:40 GMT -5
$PLPL +28% she soared over $3 bucks early!!! they may have ended 2013 slowly and started 2014 low, but the company is now catching fire!  |
|
|
|
Post by Hot Christian Stocks on Feb 4, 2014 9:08:46 GMT -5
$PLPL Plandaí lays the groundwork for its future cannabis deal with Diego Pellicer, Inc. and Diego Pellicer WorldwideNEW YORK, NY -- (Marketwired) -- 02/04/14 Plandaí Biotechnology (OTCQB: PLPL) recently entered into what could very well be the industry's biggest agreement to date. At the time, many investors may have viewed it as just another licensing agreement, but as Plandaí lays the groundwork for its future, the deal with Diego Pellicer, Inc. and Diego Pellicer Worldwide permits the company to use the Diego Pellicer name for its Phytofare cannabis extracts. But, at the same time, it put Plandaí in business with Jamen Shively, a former Microsoft executive and the co-founder of Diego Pellicer, Inc. Stock Market Media Group (SMMG), a full service research and content development investor relations firm, has seen what a media darling Jamen Shively is and how enamored that same media is with his concept to brand Cannabis under his great grandfather's name, Diego Pellicer. So, we wanted to speak directly with the source to talk about the marijuana industry, and his partnership with Plandaí. SMMG: What attracted you most to Plandaí Biotechnology? Jamen: "What most attracts me to Plandaí are its people, their vision, and the amazing technology Plandaí has developed for dramatically increasing the bioavailability of a broad range of plant extracts for application to an even broader range of both preventive and therapeutic health. Plandaí's technology, and the genius and innovation within the company which has brought it forth, are enabling both humans and animals to finally take much fuller advantage of plant nutrients, providing much healthier and more effective alternatives to synthetic pharmaceuticals. And, while my initial interest in Plandaí is the application of this technology to Cannabis for medical purposes, I am also extremely excited by the potential of the technology to create solutions which address the full range of human health and nutrition." SMMG: With your intent to become "the retail Cannabis brand" in the US and the world, do you find that branding Plandaí's Cannabis extracts gives Diego Pellicer a foothold in the medical marijuana space as well? Jamen: "Absolutely. Prior to Diego Pellicer's partnership with Plandaí, we already had a strong foothold in the medical marijuana space through a separate partnership with the Northwest Patient Resource Center, which created the gold standard for medical Cannabis dispensaries in the Pacific Northwest. Now with our partnership with Plandaí, Diego Pellicer has a platform spanning the best medical dispensary platform, combined with the very best medical Cannabis products in the world. Together, Diego Pellicer and Plandaí are poised to revolutionize the medical Cannabis industry worldwide." SMMG: You have talked about earning 40% of the marijuana market worldwide, how can Plandaí's extracts help you realize that number? Jamen: "Plandaí's extracts are actually crucial for capturing such a large portion of the worldwide Cannabis market. Because of the dramatic increases in yield, quality, and delivery of the finished product afforded by Plandaí's technologies, the Diego-Plandaí partnership has competitive advantages which are unmatched anywhere in the Cannabis industry. Together, our early leads spanning medical, recreational, branding, and finished products, equate to the Diego Pellicer brand becoming synonymous with the Cannabis industry. No one else even comes close." SMMG: Are you encouraged by what may be a real sea change in attitude coming out of Washington these days? Jamen: "I am extremely encouraged by the recent statements both from the President and from the Attorney General. These statements are consistent with the changing will of the American people, a substantial and growing majority of Americans support responsible legalization and regulation. The growth of this majority, in turn, is following a pattern which is very close to an exponential trend, as can be seen visually in the Gallup Poll data released in October 2013: www.gallup.com/poll/165539/first-time-americans-favor-legalizing-marijuana.aspxExtrapolating on the above trend, we can safely predict that the percentage of Americans in favor of responsible legalization will exceed 67% within the next 18 months, if not sooner. Once that critical threshold is reached, it will become politically untenable to oppose legalization, for any politician outside of perhaps the Bible Belt. Savvy government leaders, seeing this trend, are getting on the 'right side' of the debate sooner rather than later." SMMG: With both Florida and Ohio adding the issue to their November ballots, do you think the U.S. is closer to finally addressing full federal legalization of medical marijuana, at the very least, given they're both outside the typical pockets of support? Jamen: "First of all, on a personal note, my father, grandfather, and great-grandfather Shively were all born and raised in Ohio, and my grandmother Josefina Pellicer, daughter of Diego Pellicer, married my grandfather Richard Shively in the Philippines, and they moved back to Ohio and raised their seven children there. So, Ohio is a very important part of the Pellicer legacy, in addition to being the 'heart' of the country. I think that, just as with the last three presidential elections, as go Ohio and Florida, so goes the country. All of this bodes very well for national legalization." SMMG: In your opinion, although it's a mid-term election year, can 2014 be a pivotal year in the Cannabis debate? Jamen: "There is no doubt that 2014 will be a pivotal year in the Cannabis debate. As the near exponential trend accelerates, you will see fewer and fewer people willing to be on the 'wrong side' of the debate as the facts regarding the harms caused by prohibition become both clearer and more widely known by the general public. Simply put, it is both unethical and inhumane to perpetuate the system of prohibition of Cannabis any further." finance.yahoo.com/news/marijuana-entrepreneur-jamen-shively-discusses-140000607.html
|
|
|
|
Post by Hot Christian Stocks on Feb 5, 2014 9:38:32 GMT -5
$PLPL nice daily chart ->
|
|
|
|
Post by Hot Christian Stocks on Feb 6, 2014 9:05:13 GMT -5
$PLPL Plandai Biotechnology Learning Branding and Marketing From Former Microsoft Executive Turned Marijuana Entrepreneur NEW YORK, NY--(Marketwired - Feb 6, 2014) - Plandaí Biotechnology (OTCQB: PLPL) is in good hands when it comes to the future of branding and marketing its Phytofare(TM) cannabis extracts for use in both medical and pharmaceutical marijuana applications. While Plandaí continues to develop a full range of botanical extracts using its proprietary hydrodynamic sheering process, the company can follow the lead of its new branding partner, Diego Pellicer, Inc. and its co-founder Jamen Shively, to perfect a process as important as developing the extracts themselves -- marketing them. The good news for Plandaí executives is they have a head start on the competition as businesses within the marijuana industry wait for regulations and nationwide legalization to play itself out in order to remove any legality concerns faced in using the drug for medicinal purposes. But, with the Cannabis debate still unfolding, former Microsoft executive turned marijuana entrepreneur, Jamen Shively, says there are advantages to building the brand now while others are idly waiting for the issue to be resolved. "As an avid student and practitioner of the principles of marketing and branding, I can state with authority that 'first to mind' in getting our powerful brands out into the marketplace early on, are proving decisive in capturing long-term market share." Shively has stated that he hopes to build the first retail brand of marijuana in the U.S., and eventually capture 40 percent of the market worldwide. It will be in those retail markets that Plandaí hopes to sell its cannabis extracts under the Diego Pellicer brand. When asked how big the chain of stores can get in this country, Shively said, "It's difficult to predict, especially considering that the industry will evolve, eventually away from cannabis-only retail stores to packaged cannabis products sold in a variety of retailers, much as the alcohol industry evolved during the 1930s and 40s." He added, "Having said that, the next five years, at least, will see several hundred marijuana specialty retail stores opening throughout the U.S." After years of helping steer Microsoft product releases, Plandaí picked a partner to learn from in Jamen Shively, who truly understands the importance of branding and knowing his audience, and in the end, it is Plandaí investors who should benefit. www.stockwatch.com/News/Item.aspx?bid=U-i1087822-U%3aPLPL-20140206&symbol=PLPL®ion=U
|
|
|
|
Post by Hot Christian Stocks on Feb 7, 2014 9:19:54 GMT -5
$PLPL announced that it closed the license agreement with Diego Pellicer, Inc. which will permit the company use of the Diego Pellicer name for its Phytofare cannabis extract in medical and pharmaceutical marijuana applications 2014-02-07 09:02 ET SEATTLE, WAvia eTeligis Planda Biotechnology, Inc. (OTCQB:PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it closed the license agreement with Diego Pellicer, Inc. which will permit the company use of the Diego Pellicer name for its Phytofare cannabis extract in medical and pharmaceutical marijuana applications. Roger Baylis-Duffield, Chairman and Chief Executive Officer of Planda Biotechnology, commented, "I want to congratulate the management teams of both Diego Pellicer and Planda for working diligently to move from a letter of intent to an executed license agreement in such a short time.Diego Pellicer has been the leading name in cannabis products for over a hundred years and represents everything that Planda stands for from a product standpoint; namely, an exhaustive dedication to quality.As we move forward towards having a market-ready product by the end of the year, we can commence building our branding and distribution channels." Planda will produce the new Diego Pellicer Gold extracts in both capsules and cannabis oil (for vapor use) in Pheroid and non-Pheroid versions to appeal to the broadest range of medicinal consumers. Under the terms of the executed license agreement, Planda can use the Diego Pellicer brand name for business-to-business sales and marketing in both domestic and international markets.Planda anticipates that the Diego Pellicer Gold extracts will be sold to various medical cannabis dispensaries in areas where such business is legal. www.stockwatch.com/News/Item.aspx?bid=U-et1870130824-U%3aPLPL-20140207&symbol=PLPL®ion=U |
|
